Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus

BACKGROUND: Recent guidelines for SLE recommend using a hydroxychloroquine (HCQ) dose less than 5.0 mg/kg/day to reduce the risk of retinopathy. To determine if this dose reduction would have an impact on the clinical course of SLE, we compared flare incidence in a cohort of patients with SLE treate...

Descripción completa

Detalles Bibliográficos
Autores principales: Fasano, Serena, Messiniti, Valentina, Iudici, Michele, Coscia, Melania Alessia, Ciccia, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Immunology and Inflammation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835942/
https://www.ncbi.nlm.nih.gov/pubmed/36631164
http://dx.doi.org/10.1136/lupus-2022-000841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835942/
https://www.ncbi.nlm.nih.gov/pubmed/36631164
http://dx.doi.org/10.1136/lupus-2022-000841

Ejemplares similares